Routine Use of an Artificial Intelligence Solution for Primary Diagnosis of Prostate Biopsies in Clinical Practice

Back

Presented: European Congress of Pathology 2023
Study objective: To assess a clinically deployed artificial intelligence (AI) decision support solution for prostate biopsies, which was previously validated at UPMC1, in primary diagnosis employed in a digital pathology workflow.
Conclusions:

  • Successful implementation of a multi-feature AI solution that automatically imparts clinically relevant diagnostic parameters regarding prostate cancer, grading, measurements, and other pathologic features at UPMC
  • The solution demonstrated high accuracy for prostate cancer detection and improved diagnostic quality
  • All pathologists feel confident in providing accurate diagnoses when reporting slides supported by Galen Prostate
  • In the near future, AI and Digital Pathology will enable UPMC to implement a Centralized Laboratory approach

Click here to download the study:

Back

About IBEX

IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis. Our AI platform is deployed worldwide, supporting pathologists and providers with AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.

By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.

About IBEX

IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis. Our AI platform is deployed worldwide, supporting pathologists and providers with AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.

By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.

How is artificial intelligence rising to the challenge in breast cancer diagnosis?

How ‘game-changing’ AI is helping discover cancer for the first time in UK | ITV News

The AI revolution in cancer diagnostics with Joseph Mossel, CEO of Ibex Medical Analytics